Market Cap 60.25M
Revenue (ttm) 0.00
Net Income (ttm) -7.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 78,100
Avg Vol 5,355,554
Day's Range N/A - N/A
Shares Out 8.89M
Stochastic %K 77%
Beta -0.68
Analysts Strong Sell
Price Target $11.00

Company Profile

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic aller...

Industry: Biotechnology
Sector: Healthcare
Phone: 289 800 9600
Address:
100 Spy Court, Markham, Canada
Sw1ngb0t
Sw1ngb0t Apr. 24 at 7:35 PM
$EDSA heave ho
0 · Reply
RKLBupupup
RKLBupupup Apr. 24 at 4:24 PM
$EDSA So what does this latest news have to do with anything?
0 · Reply
Treb3k
Treb3k Apr. 24 at 12:19 PM
$EDSA they hoodwinked us into believing there would be a steady stream of news…
1 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 23 at 9:33 PM
1 · Reply
VoxChameleon
VoxChameleon Apr. 23 at 7:57 PM
$EDSA I guess $5-8 depending on the day. Pretty simple. Bump it up high short it down. Bump It up short it down. No sellers.
0 · Reply
RKLBupupup
RKLBupupup Apr. 23 at 3:05 PM
$EDSA Dip add
0 · Reply
Moneyybaggs
Moneyybaggs Apr. 23 at 1:46 PM
$EDSA Gotta love that .27 bid-ask spread on a $7 stock! WTF?!?
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 23 at 1:52 AM
$EDSA definitely 11.50 and that brings it up to that gap ... $20+ on the horizon
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 22 at 7:56 PM
$SST $ANNA $AIFF $PLYX $EDSA not one new ticker since April 1st that meets my epic criteria...at least we've got these beauts to play with #greatagain
0 · Reply
bachsong
bachsong Apr. 22 at 6:00 PM
$PZZA ($KODK and $EDSA)...$PZZA... buyout IMO to be finalize over this weekend ... to be announced Monday or before April 30th...@ $49.50-$55.00 Too bad you are short @optionwayismoneyway!!! Look at 50% potential in $KODK and $EDSA....MEANWHILE: The April 30th SH meeting is not just a formality this year; it is the ultimate deadline for the Board to avoid a public confrontation. Simple Majority Vote: As noted in the Proxy Statement filed on March 26, the Board is actually proposing an amendment to move to a simple majority vote for bylaw changes. While intended as a "shareholder-friendly" move, Irenic Capital can weaponize this immediately to force a sale if the Board rejects the $49.50 offer. The "MOU" Window: Typically, in these scenarios, if a "friendly" deal is going to happen, a Memorandum of Understanding is announced roughly 5–7 days before the meeting (which would be late this week or Monday morning). This allows the Board to walk into the meeting with a "victory", not a fight.
1 · Reply
Latest News on EDSA
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

Feb 13, 2026, 4:20 PM EST - 2 months ago

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results


Edesa Biotech Reports Fiscal Year 2025 Results

Dec 12, 2025, 4:20 PM EST - 4 months ago

Edesa Biotech Reports Fiscal Year 2025 Results


Edesa Biotech Announces Upcoming Conference Schedule

Oct 31, 2025, 4:30 PM EDT - 6 months ago

Edesa Biotech Announces Upcoming Conference Schedule


Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

Aug 8, 2025, 4:35 PM EDT - 9 months ago

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results


Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

May 14, 2025, 4:15 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results


Edesa Biotech Announces Chief Financial Officer Transition

Apr 4, 2025, 4:15 PM EDT - 1 year ago

Edesa Biotech Announces Chief Financial Officer Transition


Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

Feb 14, 2025, 4:15 PM EST - 1 year ago

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results


Edesa Biotech Reports Fiscal Year 2024 Results

Dec 13, 2024, 4:30 PM EST - 1 year ago

Edesa Biotech Reports Fiscal Year 2024 Results


Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results

Aug 9, 2024, 4:20 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results


Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

May 10, 2024, 4:15 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results


Edesa Biotech to Participate in Upcoming Investor Conferences

Apr 2, 2024, 9:00 AM EDT - 2 years ago

Edesa Biotech to Participate in Upcoming Investor Conferences


Edesa Biotech to Participate in Upcoming Dermatology Meetings

Mar 4, 2024, 4:30 PM EST - 2 years ago

Edesa Biotech to Participate in Upcoming Dermatology Meetings


Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

Feb 9, 2024, 4:15 PM EST - 2 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results


Edesa Biotech Reports Fiscal Year 2023 Results

Dec 15, 2023, 4:10 PM EST - 2 years ago

Edesa Biotech Reports Fiscal Year 2023 Results


Edesa Biotech to Present at Dermatology Drug Development Summit

Oct 26, 2023, 4:05 PM EDT - 2 years ago

Edesa Biotech to Present at Dermatology Drug Development Summit


Edesa Biotech Announces One-for-Seven Reverse Share Split

Oct 10, 2023, 9:00 AM EDT - 2 years ago

Edesa Biotech Announces One-for-Seven Reverse Share Split


Edesa Biotech Reports Fiscal Third Quarter 2023 Results

Aug 9, 2023, 4:15 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal Third Quarter 2023 Results


Edesa Biotech Appoints Biotech Deal Veteran to CFO Role

Jun 27, 2023, 8:15 AM EDT - 3 years ago

Edesa Biotech Appoints Biotech Deal Veteran to CFO Role


Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name

Jun 15, 2023, 8:00 AM EDT - 3 years ago

Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name


Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

May 11, 2023, 4:30 PM EDT - 3 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results


Edesa Biotech to Participate in Swiss Biotech Day

Apr 20, 2023, 8:30 AM EDT - 3 years ago

Edesa Biotech to Participate in Swiss Biotech Day


Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

Feb 10, 2023, 9:00 AM EST - 3 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results


FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate

Dec 20, 2022, 8:30 AM EST - 3 years ago

FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate


Edesa Biotech Reports Fiscal Year 2022 Results

Dec 16, 2022, 9:00 AM EST - 3 years ago

Edesa Biotech Reports Fiscal Year 2022 Results


Sw1ngb0t
Sw1ngb0t Apr. 24 at 7:35 PM
$EDSA heave ho
0 · Reply
RKLBupupup
RKLBupupup Apr. 24 at 4:24 PM
$EDSA So what does this latest news have to do with anything?
0 · Reply
Treb3k
Treb3k Apr. 24 at 12:19 PM
$EDSA they hoodwinked us into believing there would be a steady stream of news…
1 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 23 at 9:33 PM
1 · Reply
VoxChameleon
VoxChameleon Apr. 23 at 7:57 PM
$EDSA I guess $5-8 depending on the day. Pretty simple. Bump it up high short it down. Bump It up short it down. No sellers.
0 · Reply
RKLBupupup
RKLBupupup Apr. 23 at 3:05 PM
$EDSA Dip add
0 · Reply
Moneyybaggs
Moneyybaggs Apr. 23 at 1:46 PM
$EDSA Gotta love that .27 bid-ask spread on a $7 stock! WTF?!?
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 23 at 1:52 AM
$EDSA definitely 11.50 and that brings it up to that gap ... $20+ on the horizon
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 22 at 7:56 PM
$SST $ANNA $AIFF $PLYX $EDSA not one new ticker since April 1st that meets my epic criteria...at least we've got these beauts to play with #greatagain
0 · Reply
bachsong
bachsong Apr. 22 at 6:00 PM
$PZZA ($KODK and $EDSA)...$PZZA... buyout IMO to be finalize over this weekend ... to be announced Monday or before April 30th...@ $49.50-$55.00 Too bad you are short @optionwayismoneyway!!! Look at 50% potential in $KODK and $EDSA....MEANWHILE: The April 30th SH meeting is not just a formality this year; it is the ultimate deadline for the Board to avoid a public confrontation. Simple Majority Vote: As noted in the Proxy Statement filed on March 26, the Board is actually proposing an amendment to move to a simple majority vote for bylaw changes. While intended as a "shareholder-friendly" move, Irenic Capital can weaponize this immediately to force a sale if the Board rejects the $49.50 offer. The "MOU" Window: Typically, in these scenarios, if a "friendly" deal is going to happen, a Memorandum of Understanding is announced roughly 5–7 days before the meeting (which would be late this week or Monday morning). This allows the Board to walk into the meeting with a "victory", not a fight.
1 · Reply
EireTrader
EireTrader Apr. 22 at 2:56 PM
$EDSA... Worth waiting for
0 · Reply
WelshDragon75
WelshDragon75 Apr. 22 at 1:36 PM
$EDSA who sells out now?!
1 · Reply
Rmank47
Rmank47 Apr. 22 at 12:22 AM
$EDSA …I’m good…💰💵🤑
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 21 at 8:10 PM
$SST (looks primed) $ANNA $AIFF $PLYX $EDSA
0 · Reply
JoeDomiano
JoeDomiano Apr. 21 at 8:05 PM
$EDSA En Fuego
0 · Reply
jrml1957
jrml1957 Apr. 21 at 2:44 PM
$EDSA Rinse and repeat. Heading for highest close of the year ($7.78).
0 · Reply
Moneyybaggs
Moneyybaggs Apr. 21 at 1:40 PM
$EDSA YAY!!! We’re back to a BIG FAT DOLLAR presplit!!! Miracles will never cease. FMTT!!!
0 · Reply
Rmank47
Rmank47 Apr. 21 at 2:41 AM
$EDSA 🤑🤑🤑
0 · Reply
RKLBupupup
RKLBupupup Apr. 21 at 1:33 AM
$EDSA EDSA$6.97 +$1.04 (+17.09%)
0 · Reply
Sw1ngb0t
Sw1ngb0t Apr. 20 at 10:04 PM
$ANNA $SST $AIFF $PLYX $EDSA I like ANNA for taco tuesday... good value imo
0 · Reply
EireTrader
EireTrader Apr. 20 at 5:54 PM
$EDSA ATS
0 · Reply
JoeDomiano
JoeDomiano Apr. 20 at 4:22 PM
$EDSA En Fuego
0 · Reply